Asymchem Laboratories (Tianjin) Co., Ltd.
Research Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) on Bullrun: market cap HKD 49.80B, P/E 42.1, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6821.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 49.80B
- P/E42.1
- Dividend yield1.2%
- Financial periodQ2 2026
- RevenueCNY 1.80B
- Net incomeCNY 216.14M
- Free cash flow-CNY 211.75M
- Gross margin41.5%
Valuation Snapshot
latest market cap is HKD 49.80B; P/E is 42.1; dividend yield is 1.2%.
Peer valuation comparison
Latest P/E is 42.08x versus a Healthcare sector median of 21.8x (93.1% above).
Latest dividend yield is 1.21% versus a Healthcare sector median of 2.4% (49.6% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 49.80B | 42.1 | 1.1% | 1.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.5 HKD, yield 1.2%.
About Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business.
ETFs that hold Asymchem Laboratories (Tianjin) Co., Ltd.
US-listed ETFs
Asymchem Laboratories (Tianjin) Co., Ltd. is held by 4 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| BNY Mellon Emerging Markets Equity ETF (BKEM) | <0.01% | 0.11% |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF (GSEE) | <0.01% | 0.36% |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF (EMCR) | 0.01% | 0.15% |
| Goldman Sachs MarketBeta(R) Total International Equity ETF (GXUS) | <0.01% | 0.18% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Asymchem Laboratories (Tianjin) Co., Ltd.'s market cap?
Asymchem Laboratories (Tianjin) Co., Ltd.'s market capitalization is HKD 49.80B.
What is Asymchem Laboratories (Tianjin) Co., Ltd.'s P/E ratio?
Asymchem Laboratories (Tianjin) Co., Ltd.'s price-to-earnings (P/E) ratio is 42.1.
Does Asymchem Laboratories (Tianjin) Co., Ltd. pay a dividend?
Asymchem Laboratories (Tianjin) Co., Ltd. has a dividend yield of 1.2%.
What does Asymchem Laboratories (Tianjin) Co., Ltd. do?
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business.